The liver is the largest internal organ in the body and hepatic function is crucial to good health. A variety of analytes are designated as routine markers of liver disease. When used together in panels or individually, they can help detect and monitor hepatic disease.
For in vitro diagnostics use.
Abbott's liver function assays are designed to help evaluate liver health. Albumin is the major blood protein and is produced by the liver. Two dye binding assays, BCG and BCP, are used to measure albumin, which is decreased or increased in various diseases. The common liver enzymes ALT and AST are important markers for conditions such as hepatitis.
Hepatic malfunction is indicated by abnormal levels of direct and total bilirubin. Ammonia is a marker of acute liver failure and the enzyme GGT is associated with alcohol abuse and liver cirrhosis. Bile acids produced by the liver are necessary to lipid metabolism. All of these can be used to narrow and accurately assess disease states and treatment options.
| Liver Disease |
| Albumin (BCG) |
| Albumin (BCP) |
| Alkaline Phosphatase |
| Alpha-1 Antitrypsin |
| ALT (Alanine Aminotransferase) |
| ALT, Activated (Alanine Aminotransferase) |
| Ammonia |
| AST (Aspartate Aminotransferase) |
| AST, Activated (Aspartate Aminotransferase) |
| Bile Acids |
| Cholinesterase |
| Cholinesterase/Dibucain |
| Direct Bilirubin |
| GGT (Gamma-Glutamyl Transferase) |
| Lactate Dehydrogenase (LD) |
| PIVKA-II |
| Total Bilirubin |
| Hepatitis |
| Anti-HBc |
| Anti-HBc IgM |
| Anti-HBc II |
| Anti-HBe |
| Anti-HBs |
| Anti-HCV |
| HAVAb IgG |
| HAVAb IgM |
| HBeAg |
| HBeAg (Quantitative) |
| HBeAg Qualitative/Quantitative |
| HBsAg (Quantitative) |
| HBsAg (Quantitative) Confirmatory |
| HBsAg Next Confirmatory |
| HBsAg Next Qualitative |
| HBsAg Qualitative II |
| HBsAg Qualitative II Confirmatory |
| HCV Ag |
Login or register for a new account on the Lab Central customer portal. Here you can view assay specific package inserts for intended use, important safety information and manage your personalized lab metrics.
Scientists at Abbott and market experts are continuously working together to solve today's challenges, understand future needs and eliminate gaps in the diagnosis of hepatitis infected patients and in our overall health care community. Abbott continues to research and invest in expanding hepatitis-testing options to a variety of diagnostic platforms.
Links com outros sites que não pertençam aos sites mundiais da Abbott não estão sob o controle da Abbott. A Abbott não se responsabiliza pelo conteúdo desses sites nem por outros links a partir desses sites. A Abbott fornece esses links apenas por conveniência. A inclusão de qualquer link não implica endosso do site vinculado por parte da Abbott. O site que você solicitou pode também não estar otimizado para o tamanho da sua tela.
Vale ressaltar que o site que você solicitou se destina aos residentes de um determinado país ou países, conforme observado no respectivo site. Por isso, o site pode conter informações sobre produtos farmacêuticos, dispositivos médicos e outros produtos ou aplicações de produtos que não sejam aprovadas em outros países ou regiões.
